Screener
Sutro Biopharma STRO Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Sutro Biopharma’s 10-Q, filed November 13, 2024. Open the filing →
- Filed
- Nov 13, 2024
- Fiscal quarter
- Q3 FY2024
- Calendar quarter
- Q3 2024
- Accession
- 0000950170-24-126407
FAQ
- What is Sutro Biopharma's return on invested capital?
- Sutro Biopharma (STRO) reported return on invested capital of -142.7% in Q3 2023.
- How has Sutro Biopharma's return on invested capital changed year-over-year?
- Sutro Biopharma's return on invested capital decreased by 209.1% year-over-year, from -46.2% to -142.7%.
- What is the long-term trend for Sutro Biopharma's return on invested capital?
- Over 2 years (2020 to 2022), Sutro Biopharma's return on invested capital has grown at a 1.5% compound annual growth rate (CAGR), from -50.1% to -51.6%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Sutro Biopharma's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude